| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/04/2006 | CN1717488A Recombinant poxvirus comprising at least two cowpox ATI promoters |
| 01/04/2006 | CN1717487A Neomycin-phosphotransferase-genes and methods for the selection for recombinant cells producing high levels of a desired gene product |
| 01/04/2006 | CN1717483A Human artificial chromosome (HAC) vector |
| 01/04/2006 | CN1717479A Method and apparatus of culturing pluripotent stem cells |
| 01/04/2006 | CN1717478A Feeder cell layer for culturing human embryonic stem cells in ratio and method for culturing embryonic stem cells |
| 01/04/2006 | CN1717477A Restoration of methylation states in cells |
| 01/04/2006 | CN1717418A Antibody for the thyrotropin receptor and uses thereof |
| 01/04/2006 | CN1717177A Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 01/04/2006 | CN1715416A Agrobacterium mediated transformation system for obtaining perennial rye-grass transgenic plant in high efficiently and its use |
| 01/04/2006 | CN1715401A Method for breeding herd bull |
| 01/04/2006 | CN1715400A Method for freezing and storaging lymphocyte |
| 01/04/2006 | CN1715296A Recombinant human mannan-binding lectin |
| 01/04/2006 | CN1714614A Method and system for producing manufactured seeds |
| 01/04/2006 | CN1234868C Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
| 01/04/2006 | CN1234867C Novel bacillus thuringiensis insecticidal proteins |
| 01/04/2006 | CN1234854C Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/04/2006 | CN1234852C False virosome vaccine with recombinant replica of dengue fever virus as carrier |
| 01/04/2006 | CN1234851C Vaccine for human papilloma virus |
| 01/04/2006 | CN1234850C Somatic embryogemic regeneration of Acacia mangium |
| 01/04/2006 | CN1234731C Human erythropoietin Fc fusion protein with high bioactivity |
| 01/04/2006 | CN1234730C Mouse antichloromycetin monoclonal antibody and its use |
| 01/04/2006 | CN1234720C Detection systems for registering protein interactions and functional relationships |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/03/2006 | US6982371 improved herbicide/insect/disease resistance; horticulture |
| 01/03/2006 | US6982369 transgenic seeds/plants; horticulture; improved herbicide/insect/disease resistance; improved fatty acid/carbohydrate metabolism |
| 01/03/2006 | US6982363 UDP-glucose modifiers |
| 01/03/2006 | US6982327 Methods for producing and transforming cassava protoplasts |
| 01/03/2006 | US6982322 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 01/03/2006 | US6982171 Housing comprising a support and top member; wells configured to receive sample; use for understanding disease processes and developing and evaluating drugs |
| 01/03/2006 | US6982159 Trichoderma β-glucosidase |
| 01/03/2006 | US6982148 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis |
| 01/03/2006 | US6982095 Capsules containing vital cells or tissues |
| 01/03/2006 | US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 01/03/2006 | US6982083 Starch granules containing a recombinant polypeptide of interest, method for obtaining them, and their uses |
| 01/03/2006 | US6982082 Gene therapy by cell specific targeting |
| 01/03/2006 | CA2329510C Promoter sequence which is expressed in anthers and in pollen |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 12/29/2005 | WO2005124346A1 4-1bb receptors are expressed on regulatory t-cells |
| 12/29/2005 | WO2005123929A2 Plastid transit peptides |
| 12/29/2005 | WO2005123928A1 Production of human coagulation factor viii from plant cells and whole plants |
| 12/29/2005 | WO2005123919A1 Plant polynucleotide promoter sequences from lolium festuca and arabidopsis |
| 12/29/2005 | WO2005123918A1 Expression vector capable of regulating the induction of foreign gene expression |
| 12/29/2005 | WO2005123909A2 Isolation and characterization of muscle regenerating cells |
| 12/29/2005 | WO2005123908A2 Novel cancer cell lines and uses thereof |
| 12/29/2005 | WO2005123907A2 Ex-vivo application of solid microparticulate therapeutic agents |
| 12/29/2005 | WO2005123906A1 Method of increasing amount of insulin secreted and/or produced by insulin-producing cell |
| 12/29/2005 | WO2005123905A1 Cell culturing method by biomechanical stimulus load and its device |
| 12/29/2005 | WO2005123904A1 Method of producing vascular endothelial cells from primate embryonic stem cells |
| 12/29/2005 | WO2005123903A2 Culture aid for cells and tissues |
| 12/29/2005 | WO2005123902A1 Method of inducing the differentiation of embryonic stem cells into nerve by serum-free suspension culture |
| 12/29/2005 | WO2005123901A2 Stem cell maturation for all tissue lines |
| 12/29/2005 | WO2005123900A1 Medium and methods for culturing of avian primordial germ cells |
| 12/29/2005 | WO2005123779A2 Antibodies binding to cd34+/cd36+ fetal but not to adult cells |
| 12/29/2005 | WO2005123769A1 Hla-a2-binding protein originating in prostate-related antigen |
| 12/29/2005 | WO2005123258A1 Bioreactor for studying the effects of imposed stimuli on cellular activity |
| 12/29/2005 | WO2005123123A2 Therapeutic reprogramming, hybrid stem cells and maturation |
| 12/29/2005 | WO2005122750A2 Novel maize split-seed explant and methods for in vitro regeneration of maize |
| 12/29/2005 | WO2005094576A3 Cryopreservation media |
| 12/29/2005 | WO2005094364A3 Iga antibody protein as a cytotoxic drug |
| 12/29/2005 | WO2005086845A3 Compositions and methods for growth of embryonic stem cells |
| 12/29/2005 | WO2005086654A3 Self-cleaving affinity tags and methods of use |
| 12/29/2005 | WO2005084387A3 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer |
| 12/29/2005 | WO2005072364A3 A modified baculovirus expression system for production of pseudotyped raav vector |
| 12/29/2005 | WO2005067500A3 Enhancement of immune responses |
| 12/29/2005 | WO2005065309A3 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 12/29/2005 | WO2005048943A3 Compositions and methods for synergistic induction of antitumor immunity |
| 12/29/2005 | WO2005037190A3 Multiplex vaccines |
| 12/29/2005 | WO2005026319A3 Erythrocytic cells and method for loading solutes |
| 12/29/2005 | WO2005023996A3 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 12/29/2005 | WO2004094599A3 Disease prevention and vaccination following thymic reactivation |
| 12/29/2005 | WO2004035758A3 Rna-based inhibitory oligonucleotides |
| 12/29/2005 | WO2004015073A3 MP21S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 12/29/2005 | WO2004013280A3 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING |
| 12/29/2005 | WO2003071933A3 Novel compositions and methods for cancer |
| 12/29/2005 | WO2002099040A3 Igs as modifiers of the p53 pathway and methods of use |
| 12/29/2005 | US20050289670 Plant myo-inositol kinase polynucleotides and methods of use |
| 12/29/2005 | US20050289669 TTG3 deficient plants, nucleic acids, polypeptides and methods of use thereof |
| 12/29/2005 | US20050289664 Genes encoding 4-Hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288867 Cell tissue culture management method and system |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288248 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 12/29/2005 | US20050288247 Inducible inactivation of synaptic transmission |
| 12/29/2005 | US20050288225 Modulators of intracellular inflammation, cell death and cell survival pathways |
| 12/29/2005 | US20050288220 Erythropoietin with high specific activity |
| 12/29/2005 | US20050288216 Novel transformed cell, method of screening antiaging agent and antiaging agents |
| 12/29/2005 | US20050287670 Cell culturing systems, methods and apparatus |
| 12/29/2005 | US20050287669 Nucleic acid construct and expression vector for enhancing the production of recombinant protein, and method for the massive production of recombinant protein |
| 12/29/2005 | US20050287666 Cell culture medium comprising transition metals or trace elements |
| 12/29/2005 | US20050287665 Using stem cell culture comprising dibutyryl cAMP and pituitary adenylate cyclase-activating polypeptide (PACAP) as therapeujtic treating spinal cord injuries |
| 12/29/2005 | US20050287664 Cellular proliferation control factors |
| 12/29/2005 | US20050287663 DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor |
| 12/29/2005 | US20050287662 Helper-free stocks of recombinant adeno-associated virus vectors |
| 12/29/2005 | US20050287647 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 12/29/2005 | US20050287644 Methods for producing and culturing rabbit-mouse hybridomas and monoclonal antibodies secreted by rabbit-mouse hybridomas |
| 12/29/2005 | US20050287642 Efficient protein expression system |